Moderna rises 2.3% as firm starts COVID-19 vaccine trial in kids

16.03.2021 - Davydova Maria
Moderna rises 2.3% as firm starts COVID-19 vaccine trial in kids

Shares of Moderna went up 2.3% on Tuesday after the vaccine producer reported it had started its VOCID-19 vaccine trial in children aged between six months and 12 years old.

The vaccine trial will be highly indicative of the efficacy of Moderna’s developed COVId-19 immunization for kids. The vaccine, named mRNA-1273, will be given in two doses. Around 6,750 children from Canada and the United States are targeted to be subject to the study.

In America, Moderna’s COVID-19 vaccine has already been authorized for emergency use for people 18 years and above. Since the inoculation rollout, the vaccine was proven effective without many cases of major side effects reported. Moderna is already testing the shot in people ages between 12 and 18 years.

Another contributing factor to Moderna’s stock surge is the smooth and fast inoculation rollout in the United States.

Risk disclaimer "PROMETHEUS LTD – Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Republic of the Marshall Islands MH96960 is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0155 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of PROMETHEUS LTD and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from umarkets.net or PROMETHEUS LTD." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue
×

Help with deposit?